SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crow with knife community is rallying around the project's recent website update and its multi-chain capabilities, positioning it as a standout in the meme coin sector. Investors are actively discussing its deflationary burn mechanism and potential for growth as they work to expand the project's presence across multiple blockchain networks.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is currently under pressure as investors react to concerns over potential credit card interest rate caps and regulatory scrutiny regarding transaction fees. Despite the market volatility and ongoing political debates, long-term participants continue to emphasize the company's entrenched global payment network and high profit margins, leading many to view the price dip as a potential entry opportunity.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

Investors are actively debating the long-term potential of the 4CHAN token, positioning it as a foundational "index fund" of meme culture with significant upside should it capture broader adoption. While some community members remain skeptical of volatility and price action, proponents emphasize the token's cultural roots, low market capitalization, and historical significance as catalysts for a potential major rally.

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Medtronic Plc

Medtronic is capturing market attention following a fiscal third-quarter earnings report that surpassed analyst expectations on both earnings and revenue, despite initial share price volatility tied to cautious full-year guidance and tariff-related impacts. The community is actively debating the company's long-term value, with active discussions focusing on its dividend reliability, potential for M&A-driven growth in cardiovascular and diabetes segments, and the impact of the upcoming MiniMed spinoff.

Asana, Inc. engages in the business of developing a work management platform that helps organizations orchestrate work from daily tasks to cross-functional strategic initiatives. The company was founded by Dustin Moskovitz and Justin Michael Rosenstein on December 16, 2008 and is headquartered in San Francisco, CA.

Asana Inc - Ordinary Shares - Class A

Asana Inc

Asana is seeing significant market activity driven by aggressive insider accumulation, specifically from CEO Dustin Moskovitz, who has been consistently purchasing large volumes of shares. While the stock faces ongoing pressure from high operating losses and intense competition, the community is closely monitoring these insider buys as a potential signal for a turnaround or a strategic shift, leading to speculation about a possible future acquisition or long-term value play.

Helmerich & Payne, Inc. engages in the provision of drilling solutions and technologies. It operates through the following segments: North America Solutions, Offshore Solutions, International Solutions, and Others. The North America Solutions segment focuses on the operation of the AC drive drilling rig fleet. The Offshore solutions segment refers to the seven platform rigs located in U.S. federal waters. The International Solutions segment includes Argentina, Colombia, Bahrain, and United Arab Emirates. The Other segment involves BENTEC manufacturing and engineering operations. The company was founded by Walter Hugo Helmerich II and William Payne in 1920 and is headquartered in Tulsa, OK.

Helmerich & Payne, Inc.

Helmerich & Payne is trending as investors weigh a recent earnings miss against broader optimism regarding US land drilling demand and geopolitical tailwinds. The community is actively debating the company's long-term potential as a drilling market leader, with many sentiment-focused discussions highlighting its value as a stock that remains underappreciated relative to the energy sector's ongoing operational activity.

Patterson-UTI Energy, Inc. engages in the provision of drilling and pressure pumping services, directional drilling, rental equipment, and technology. It operates through the following segments: Drilling Services, Completion Services, and Drilling Products. The Drilling Services segment represents contract drilling, directional drilling, oilfield technology, and electrical controls and automation businesses. The Completion Services segment offers hydraulic fracturing, wireline and pumping, completion support, cementing, and pressure pumping business. The Drilling Products segment focuses on manufacturing and distribution of drill bits business. The company was founded by Cloyce A. Talbott and A. Glenn Patterson in 1978 and is headquartered in Houston, TX.

Patterson-UTI Energy Inc

Patterson-UTI Energy is trending as investors monitor the company's international expansion into Argentina's Vaca Muerta region and the ongoing industry-wide focus on drilling efficiency. The community is actively discussing its leverage to energy prices, with many debating whether the current stock valuation offers a compelling entry point for long-term exposure to U.S. land drilling and production.

iShares Trust - iShares 0-3 Month Treasury Bond ETF

iShares 0-3 Month Treasury Bond ETF

Investors are increasingly flocking to SGOV as a safe-haven parking spot for cash, driven by its stability and monthly dividend payouts amid ongoing concerns regarding market volatility and economic uncertainty. The community views the ETF as a defensive alternative to equities, frequently discussing it as a low-risk strategy to protect capital while waiting for clearer market signals or potential corrections.

Shido

Shido is gaining significant community attention as the project continues to expand its L1 ecosystem, fueled by the recent launch of BubbleStaking and progress toward the Nova EVM architecture. Investors are actively discussing the platform's focus on high-performance infrastructure, including instant finality and the upcoming transition to an agentic economy, as they watch for further milestones on the network roadmap.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is currently facing intense community debate regarding its long-term viability and labor practices, fueled by a combination of a significant $100 million insider stock purchase and widespread driver dissatisfaction over compensation. Investors remain divided between the company's strong marketplace growth and concerns over margin compression, regulatory headwinds, and the potential impact of AI automation on its workforce.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immix Biopharma (NASDAQ:IMMX) Shares Down 8.9% - Should You Sell?

Immix Biopharma (NASDAQ:IMMX) Trading Down 8.9% - What's Next...

Immix Biopharma (NASDAQ:IMMX) Trading Up 6.3% - What's Next?

Immix Biopharma (NASDAQ:IMMX) Trading Up 6.3% - Should You Buy...

Short Interest in Immix Biopharma, Inc. (NASDAQ:IMMX) Drops By 13.4%

Immix Biopharma, Inc. (NASDAQ:IMMX - Get Free Report) was the target of a significant decrease in short interest during the month of February. As of February 27th, there was short interest totaling...

Immix Biopharma (NASDAQ:IMMX) Hits New 12-Month High - Here's Why

Immix Biopharma (NASDAQ:IMMX) Sets New 52-Week High - Should You Buy...

Immix Biopharma (IMMX) to Release Earnings on Monday

Immix Biopharma (NASDAQ:IMMX) will be releasing its Q4 2025 earnings before the market opens on Monday, March 23. (View Earnings Report at...

Immix Biopharma (NASDAQ:IMMX) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen lowered Immix Biopharma from a "hold" rating to a "sell" rating in a research report on Sunday...

Immix Biopharma (NASDAQ:IMMX) Hits New 12-Month High - Should You Buy?

Immix Biopharma (NASDAQ:IMMX) Sets New 12-Month High - Here's What Happened...

Immix Biopharma (NASDAQ:IMMX) Coverage Initiated by Analysts at Citizens Jmp

Citizens Jmp began coverage on shares of Immix Biopharma in a research report on Monday. They issued a "market outperform" rating and a $23.00 price target for the company...

Immix Biopharma (NASDAQ:IMMX) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded Immix Biopharma from a "sell" rating to a "hold" rating in a research report on Saturday...

Short Interest in Immix Biopharma, Inc. (NASDAQ:IMMX) Rises By 31.9%

Immix Biopharma, Inc. (NASDAQ:IMMX - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 30th, there was short interest totaling...

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Current Price	$9.11
Prev Close	$9.68
Open	$9.60
Dividend Yield	0.00%
50-Day Moving Average	$7.33
Beta	1.28
Avg. Volume	808,732.60
PE Ratio	-11.59

52-Week High	$11.61
52-Week Low	$1.34
Market Capitalization	$482.42M
EPS (Annual)	-$0.7641
Price to Book	36.41
Revenue Per Employee	$0.00

IMMX
Immix Biopharma Inc

Feed

News

Sentiment

Fundamentals

Info

Latest IMMX News

IMMXImmix Biopharma Inc